Galtec Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Galtec General Information
Description
Operator of an immuno-therapy company intended to develop successful monoclonal antibodies for cancer treatment and autoimmune diseases. The company has a group of scientists who transform the scientific findings of their research into new drugs based on the modulation of galectins for the treatment of cancer, autoimmunity, and chronic inflammatory diseases, enabling the healthcare industry to generate new therapeutic opportunities that positively impact the quality of life of the population.
Contact Information
Website
www.galtec.arCorporate Office
- Vuelta de Obligado 2490
- Ciudad de
- Buenos Aires
- Argentina
Corporate Office
- Vuelta de Obligado 2490
- Ciudad de
- Buenos Aires
- Argentina
Galtec Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jan-2023 | Completed | Generating Revenue |
Galtec Signals
Galtec Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| White Lions | Angel Group | Minority |
Galtec FAQs
-
When was Galtec founded?
Galtec was founded in 2023.
-
Where is Galtec headquartered?
Galtec is headquartered in Buenos Aires, Argentina.
-
What is the size of Galtec?
Galtec has 6 total employees.
-
What industry is Galtec in?
Galtec’s primary industry is Drug Discovery.
-
Is Galtec a private or public company?
Galtec is a Private company.
-
What is Galtec’s current revenue?
The current revenue for Galtec is .
-
Who are Galtec’s investors?
White Lions has invested in Galtec.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process